Crystal Structure of the Human Cannabinoid Receptor CB2

Area of Science:

• Structural biology
• Pharmacology
• Immunology

Background:

• Cannabinoid receptor CB2 is primarily in the immune system.
• Selective CB2 modulation offers therapeutic potential for inflammatory, fibrotic, and neurodegenerative diseases, avoiding CB1 receptor's psychoactivity.

Purpose of the Study:

• Determine the crystal structure of human CB2 with antagonist AM10257.
• Investigate the molecular basis of CB2 and CB1 receptor function and selectivity.
• Gain insights into the CB2 receptor activation mechanism for rational drug design.

Main Methods:

• X-ray crystallography (2.8 Å resolution) of human CB2-AM10257 complex.
• Mutagenesis studies.
• Molecular docking simulations.

Main Results:

• The CB2-AM10257 structure revealed a unique binding pose compared to CB1.
• A conformational similarity between antagonist-bound CB2 and agonist-bound CB1 was observed.
• AM10257 demonstrated opposing functional profiles: CB2 antagonism and CB1 agonism.
• Molecular analyses elucidated the basis for CB2 and CB1 function and selectivity.

Conclusions:

• The study provides the crystal structure of human CB2 complexed with an antagonist.
• Findings facilitate rational drug design for precise modulation of the endocannabinoid system.
• Insights into CB2 activation mechanisms are provided through analysis of designed ligand pairs.